Urolog. pro Praxi, 2006; 5: 220-225

THE IMPORTANCE OF PHYTOTHERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

MUDr. Zbyněk Veselský Ph.D
Urocentrum Praha, s.r.o

Phytotherapy – treatment with standardized, large-scale produced preparations from herbal drugs – is the oldest type of treatment of benign prostatic hyperplasia (BPH). It is based on experience and knowledge which are sometimes verified empirically rather than being clearly evidenced by aetiopathogenic action. It accounts for some 20 % of the treatment of BPH both in controlled and free market. The most common herbal drug is Serenoa repens (saw palmetto) which is contained in the greatest number of preparations. The second most common is Pygeum africanum (African plum). The other drugs are represented only in small numbers (one worth mention is stinging nettle – Urtica dioica); they dominate the market with parapharmaceuticals (pumpkin oil, etc.).

The pharmacological action of herbal drugs is complex. They contain a number of substances which, if in sufficient concentration, may improve lower urinary tract symptoms in themselves. According to some, administration of phytopharmaceuticals in the first year of treatment is as effective as the therapy with alpha-inhibitors, others, however, underevalue this treatment and refer to it as popular healing practice („A drug with no undesirable effects may not even have any desirable ones.“).

Keywords: Key words: phytotherapy, benign prostatic hyperplasia, Serenoa repens, Pygeum africanum.

Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veselský Z. THE IMPORTANCE OF PHYTOTHERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA. Urol. praxi. 2006;7(5):220-225.
Download citation

References

  1. Buck AC. Is there a scientific bais for therapeutics effects of Serenoa repens in benign prostatic hyperplasia? Mechanism of action. J Urol 172 (5 Pt 1): 1792-1799. Go to original source... Go to PubMed...
  2. Cristoni A, Di Pierro F, Bombardelli E. Botanical derivatives for the prostate. Fitoterapia 71 (Suppl 1): S21-28. Go to PubMed...
  3. Dreikorn K. Phytoterapeutic agents in the treatment of benign prostatic hyperplasia. Curr Urol Rep 2000; 1 (2): 103-109. Go to original source... Go to PubMed...
  4. Dreikorn K. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. Worl J Urol 2002 19 (6): 426-435. Go to original source... Go to PubMed...
  5. Dreikorn K, Berges R, Pientka L, Jonas U. Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation. Urologe A 2002; 41 (5): 447-451. Go to original source... Go to PubMed...
  6. Dvorkin L, Song KY. Herbs for benign prostatic hyperplasia. Ann Pharmacother 2002; 36 (9): 1443-1451. Go to original source... Go to PubMed...
  7. Gerber GS. Phytotherapy for benign prostatic hyperplasia. Curr Urol Rep 2002; 3 (4): 285-291. Go to original source... Go to PubMed...
  8. Katz AE. Flavonoid and botanical approaches to prostate health. J Altern Complement Med 2002; 8 (6): 813-821. Go to original source... Go to PubMed...
  9. Levin RM, Das AK. A scientic basis for the therapeutics effects of Pygeum africanum and Serenoa repens. Urol Res 2000; 28 (3): 201-209. Go to original source... Go to PubMed...
  10. Schleich S, Papaionnou M, Baniahmad A, Matusch R. Extracts from Pygeum africanum and other ethnobotanivcal species with anriandrogenic activity. Planta Med 2006: 19. Go to original source... Go to PubMed...
  11. Yarnell E. Botanical medicines for the urinary tract. World J Urol 2002; 20 (5): 285-293. Go to original source... Go to PubMed...
  12. Wilt TJ, Ishani A, Rutsk I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr 2000; 3 (4A): 459-472. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.